-
EP2515940
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2515940
| EP2515940 - IMMUNOGENIC COMPOSITIONS AND RELATED METHODS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 14.12.2018 Database last updated on 26.06.2024 | |
| Former | Examination is in progress Status updated on 17.02.2017 | Most recent event Tooltip | 14.12.2018 | Application deemed to be withdrawn | published on 16.01.2019 [2019/03] | Applicant(s) | For all designated states Sanofi Pasteur Limited 1755 Steeles Avenue West Toronto, ON M2R 3T4 / CA | [2012/44] | Inventor(s) | 01 /
HARPER, Kevin 14411 Creditview Rd Cheltenham Ontario L7C 1N3 / CA | 02 /
LJUTIC, Belma 3 Everson Drive Unit 124 Toronto Ontario M2N 7C2 / CA | 03 /
GALLICHAN, Scott 1125 Bryn Mawr Lane Burlington Ontario L7P 0E1 / CA | 04 /
OCHS, Martina, Ochs 1541 Avenue Marcel Mérieux 69280 Marcy l'Etoile / FR | 05 /
MOREFIELD, Garry 2213 Evening Sun RD Nazareth Pennsylvania 18064 / US | 06 /
SALHA, Marie-Danielle 444 Broadway Avenue Toronto Ontario M4G 2R1 / CA | 07 /
AUSAR, Fernando 250 Gas Lamp Lane Markham, Ontario L6B 1L7 / CA | [2012/44] | Representative(s) | Avidity IP Broers Building Hauser Forum 21 JJ Thomson Avenue Cambridge CB3 0FA / GB | [N/P] |
| Former [2013/03] | Blance, Stephen John, et al Avidity IP Merlin House Falconry Court Baker's Lane Epping, Essex CM16 5DQ / GB | ||
| Former [2012/44] | Mannion, Sally Kim, et al Avidity IP Ltd Merlin House Falconry Court Baker's Lane Epping, Essex CM16 5DQ / GB | Application number, filing date | 10838455.3 | 20.12.2010 | WO2010CA01975 | Priority number, date | US20090289077P | 22.12.2009 Original published format: US 289077 P | US20090289236P | 22.12.2009 Original published format: US 289236 P | US20100325615P | 19.04.2010 Original published format: US 325615 P | [2012/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011075822 | Date: | 30.06.2011 | Language: | EN | [2011/26] | Type: | A1 Application with search report | No.: | EP2515940 | Date: | 31.10.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.06.2011 takes the place of the publication of the European patent application. | [2012/44] | Search report(s) | International search report - published on: | CA | 30.06.2011 | (Supplementary) European search report - dispatched on: | EP | 11.09.2013 | Classification | IPC: | A61K39/09, A61P31/04, A61P37/04 | [2013/41] | CPC: |
A61K39/092 (EP,US);
A61K39/39 (EP,US);
A61K47/26 (EP,US);
A61K9/0019 (EP,US);
A61P31/04 (EP);
A61P37/04 (EP);
A61K2039/55505 (EP,US)
(-)
|
| Former IPC [2012/44] | A61K39/39, A61K39/02, A61K39/09, A61P31/04, A61P37/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2012/44] | Title | German: | IMMUNOGENE ZUSAMMENSETZUNGEN UND ENTSPRECHENDE VERFAHREN | [2012/44] | English: | IMMUNOGENIC COMPOSITIONS AND RELATED METHODS | [2012/44] | French: | COMPOSITIONS IMMUNOGÈNES ET MÉTHODES CORRESPONDANTES | [2012/44] | Entry into regional phase | 22.06.2012 | National basic fee paid | 22.06.2012 | Search fee paid | 22.06.2012 | Designation fee(s) paid | 22.06.2012 | Examination fee paid | Examination procedure | 22.06.2012 | Examination requested [2012/44] | 29.07.2014 | Amendment by applicant (claims and/or description) | 21.02.2017 | Despatch of a communication from the examining division (Time limit: M06) | 25.08.2017 | Reply to a communication from the examining division | 06.02.2018 | Despatch of a communication from the examining division (Time limit: M06) | 17.08.2018 | Application deemed to be withdrawn, date of legal effect [2019/03] | 12.09.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2019/03] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.02.2017 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 29.07.2014 | Request for further processing filed | 29.07.2014 | Full payment received (date of receipt of payment) Request granted | 14.08.2014 | Decision despatched | Fees paid | Renewal fee | 11.12.2012 | Renewal fee patent year 03 | 12.12.2013 | Renewal fee patent year 04 | 11.12.2014 | Renewal fee patent year 05 | 10.12.2015 | Renewal fee patent year 06 | 13.12.2016 | Renewal fee patent year 07 | 12.12.2017 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2009000826 (GLAXOSMITHKLINE BIOLOG SA [BE], et al) [X] 1,2,4-9,11-15 * page 34, line 22 - line 31; examples 14, 16; claim 78 * * page 51, line 11 - line 12 * * page 70, line 25 - page 73 * [I] 3,10; | [A]WO2009094779 (SANOFI PASTEUR LTD [CA], et al) [A] 1-15 * example 2A * | International search | [Y]CA2695169 (NOVARTIS AG [CH]); | [Y]CA2566344 (MITCHELL TIMOTHY JOHN [GB], et al); | [YP]WO2010071986 (SANOFI PASTEUR LTD [CA], et al) | [X] - JEZEK, J. ET AL., "A heat-stable hepatitis B vaccine formulation", HUMAN VACCINES., (200908), vol. 5, no. 8, pages 529 - 535 | [X] - HEM, S.L. ET AL., "Relationship between physical and chemical properties of aluminum-containing adjuvants and immunpotentiation.", EXPERT REV. VACCINES., (200710), vol. 6, no. 5, pages 685 - 698 | [X] - WITTAYANUKULLUK, A. ET AL., "Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen.", VACCINE, (20040312), vol. 22, no. 9-10, pages 1172 - 1176 | [Y] - GLOVER, D.T. ET AL., "Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis.", INFECT. IMMUN., (200806), vol. 76, no. 6, pages 2767 - 2776 | [A] - HANSEN, B. ET AL., "Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.", VACCINE, (20090205), vol. 27, no. 6, pages 888 - 892 | [A] - JONES, L.S. ET AL., "Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens", J. BIOL. CHEM., (20050408), vol. 280, no. 14, pages 13406 - 13414 | [A] - IYER, S. ET AL., "Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins.", PHARM. DEV. TECNOL., (2003), vol. 8, no. 1, pages 81 - 86 | [A] - HANSEN, B. ET AL., "Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response.", VACCINE, (2007), vol. 25, no. 34, pages 6618 - 6624 |